The Team

Protean BioDiagnostic’s unique services and vision are driven by a passionate and talented team. We are committed to making quality cancer testing available for all cancer patients.

DR. ANTHONY MAGLIOCCO, MD FRCPC FCAP

President and CEO

Dr. Magliocco is a board certified Pathologist and Professor of Oncology and Pathology with over 30 years of experience in tissue pathology, medical research, molecular diagnostics, liquid biopsy, genetics, digital image analysis and clinical trials. He founded Protean BioDiagnostics, and developed the unique Protean MAPS system. Protean MAPS is currently the only comprehensive precision medicine system aimed at supporting community based cancer patients and their doctors.

Read Full Bio >

SUSAN LEE

Chief Operating Officer

Susan has a B.Sc. in Molecular, Cellular and Microbial Biology. She has over 20 years experience in laboratory design, operations, organization, and novel assay deployment, with experience in both basic and translational research. She organized the initial formation and critical operations of clinical cancer testing laboratories including development of policies, staffing, operational development, and scalability. She is currently managing all aspects of the daily operations and expansion of Protean and assists with general business operations, accounting and human resources.

Damien Jones

Chief Information Officer

Damien has a B.Sc. in Computer Science and over twenty-five years of experience writing and developing software and leading large teams focused on creating data management software. Damien is also experienced with health data security, HIPAA regulatory, Health records, Lab information systems, digital pathology and bioinformatics. Damien is currently guiding Protean’s data management activities and creating new data management tools include cloud based health data management systems. He is working to create unique integrated reporting systems that combine multiple platforms into our clinical real-world data warehouse. He is also ensuring that clinical and mission critical data is both secure and available for advanced computational development. This will include innovative applications such as deep learning, computer vision, and artificial intelligence.

Andica Kunst

General Counsel

Andica Kunst joined Protean in October of 2021 after serving as its outside counsel since June of 2020. Over her legal career, Andica has represented both private and publicly-traded companies in a wide range of business and legal matters, including mergers and acquisitions, joint ventures, securities regulation and general corporate issues. She has advised companies in a variety of industries, ranging from biotech research firms to personal care and software developers to investment banks. Her tenure as general counsel of the 4th largest New York Stock Exchange specialist firm gave Andica a special insight and appreciation of the operational side of a business and the importance of an outcome-focused approach.

Clinical Services Team

Lisa Toomer | Laboratory Operations Manager
Daniel Heiney | Medical Technologist and Supervisor
Erica Hogan | Histotechnologist
Fautmah Babamir | Patient and Client Support
Vaughn Hamill | Molecular Technologist

Data Management Team

Daniel Franklin | Digital Pathology
Roy Khalife | Bioinformatician

Research Services Team

Hannah Park | Research Manager
Catalina Esguerra | Research Assistant
Skyler Keller | Research Assistant

Administrative Team

Julia Wong | Executive Assistant